In a follow-up to our November CEO profile, Novo Nordisk’s Jesper Høiland writes how pharma companies and insurers are learning to collaborate.
Jesper Hoiland
Advertisement
Articles by Jesper Hoiland
Advertisement
Latest Updated Articles
Beyond the Blame Game: How Pharma is Learning to CollaborateJanuary 13th 2015
Advertisement
Advertisement
Trending on PharmExec
1
Novartis, Bristol Myers Pause Autoimmune CAR-T Trials Over Safety Concerns: Report
2
Ultragenyx Shares Drop Following Failed Phase III Clinical Trial
3
FDA Approves Zanvastro for Alexander Disease in Pediatrics & Adults
4
Your Questions Answered: The Biggest Pharma and Biotech Stories This Week
5